Nutex Health (NASDAQ:NUTX) Shares Down 5.5% – Time to Sell?

Nutex Health Inc. (NASDAQ:NUTX)’s share price traded down 5.5% during mid-day trading on Wednesday . The stock traded as low as $92.16 and last traded at $91.4170. 20,433 shares traded hands during trading, a decline of 90% from the average session volume of 204,479 shares. The stock had previously closed at $96.78.

Wall Street Analyst Weigh In

A number of analysts recently issued reports on NUTX shares. Weiss Ratings restated a “hold (c)” rating on shares of Nutex Health in a report on Monday, December 29th. Wall Street Zen lowered shares of Nutex Health from a “strong-buy” rating to a “hold” rating in a research note on Saturday. Two investment analysts have rated the stock with a Buy rating and one has assigned a Hold rating to the stock. According to MarketBeat, the stock currently has an average rating of “Moderate Buy” and a consensus target price of $252.50.

Nutex Health Stock Down 8.6%

The firm has a market capitalization of $616.85 million, a P/E ratio of 9.87 and a beta of 0.03. The company has a debt-to-equity ratio of 0.70, a quick ratio of 3.39 and a current ratio of 3.41. The stock has a 50 day moving average of $133.25 and a 200-day moving average of $124.98.

Nutex Health (NASDAQ:NUTX) last issued its earnings results on Thursday, March 5th. The company reported $1.61 earnings per share for the quarter, missing analysts’ consensus estimates of $5.56 by ($3.95). Nutex Health had a return on equity of 17.67% and a net margin of 7.34%.The business had revenue of $151.68 million for the quarter, compared to the consensus estimate of $258.82 million.

Institutional Inflows and Outflows

A number of hedge funds have recently bought and sold shares of NUTX. State of Alaska Department of Revenue purchased a new stake in shares of Nutex Health during the third quarter worth $30,000. Islay Capital Management LLC purchased a new position in shares of Nutex Health in the fourth quarter valued at $34,000. BNP Paribas Financial Markets raised its stake in shares of Nutex Health by 966.7% during the 2nd quarter. BNP Paribas Financial Markets now owns 320 shares of the company’s stock valued at $40,000 after purchasing an additional 290 shares during the period. Ameritas Investment Partners Inc. bought a new stake in shares of Nutex Health during the 2nd quarter valued at $44,000. Finally, Royal Bank of Canada lifted its holdings in Nutex Health by 752.4% during the 4th quarter. Royal Bank of Canada now owns 358 shares of the company’s stock worth $59,000 after purchasing an additional 316 shares in the last quarter. 5.32% of the stock is currently owned by hedge funds and other institutional investors.

Nutex Health Company Profile

Nutex Health, Inc (NASDAQ: NUTX) is an integrated outpatient healthcare services company based in San Antonio, Texas. The company focuses on delivering a range of ambulatory care solutions, including urgent care, telemedicine, medical imaging, teleradiology, weight‐loss services and behavioral health support. By combining in‐person clinics with virtual care capabilities, Nutex Health aims to provide patients with accessible, cost‐effective treatment options outside traditional hospital settings.

The company’s urgent care network operates through both standalone and retail‐anchored centers, offering treatment for non‐life‐threatening injuries and illnesses, preventive screenings and basic primary care.